Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

FK 3311

Known as: FK-3311, FK3311 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Purpose: Our objective was to evaluate whether COX-2 inhibition with FK3311, a selective cyclooxygenase (COX)-2 inhibitor… Expand
2007
2007
Ischemia–reperfusion injury is induced by activation of the arachidonic acid cascade following the induction of cyclooxygenase-2… Expand
2007
2007
BACKGROUND/AIMS This study was designed to investigate the effects of a selective cyclooxygenase-2 inhibitor, FK3311, on warm… Expand
2006
2006
BACKGROUND Cyclooxygenase (COX) is an intracellular enzyme that converts arachidonic acid to prostaglandin endoperoxide (PGG(2… Expand
2003
2003
BACKGROUND/AIMS The purpose of this study was to investigate the effects of a selective COX-2 inhibitor, FK3311, on warm ischemia… Expand
2001
2001
BACKGROUND This study investigated the effects of a selective COX-2 inhibitor, FK3311, on warm ischemia-reperfusion (I/R) injury… Expand
2001
2001
BACKGROUND Liver grafts from non-heart-beating donors inevitably suffer from warm ischemic injury. In these grafts, large… Expand
2000
2000
T614 (3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-o ne) is a member of the family of methanesulfonanilide non… Expand
1993
1993
We synthesized putative metabolites of 4'-acetyl-2'-(2,4-difluorophenoxy)methanesulfonanilide (FK3311, 1), a novel… Expand
1993
1993
The structure of the previously reported new antiinflammatory agent (1, FK3311) was chemically modified in an attempt to find… Expand